Capsid-mediated interactions in HIV assembly
HIV组装中衣壳介导的相互作用
基本信息
- 批准号:7230861
- 负责人:
- 金额:$ 22.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAdoptedAmino Acid SequenceAmino AcidsAnti-HIV AgentsAnti-Retroviral AgentsAntiviral AgentsArchitectureBiological AssayC-terminalCapsidCapsid ProteinsCharacteristicsComplexDataDefectDevelopmentDimerizationDisruptionDominant-Negative MutationDrug Delivery SystemsDue ProcessElementsEpidemicEventGaggingHIVHIV BuddingHIV drug resistanceHealthHomologous GeneHumanIn VitroInfectious AgentLeadLibrariesLife Cycle StagesLong Terminal RepeatsMapsMass Spectrum AnalysisMediatingMethodsModelingMolecularMolecular ConformationMutagenesisNMR SpectroscopyNaturePeptidesPharmaceutical PreparationsPhenotypePreclinical Drug EvaluationProcessPropertyProteinsResearch PersonnelResistanceRetrotransposonRetroviridaeRoleScanningSideSolutionsStretchingStructureTestingViralViral ProteinsVirus-like particleZinc Fingersbasecrosslinkdesigndimergag Gene Productshigh throughput screeningin vivoinhibitor/antagonistinsightmutantnovelparticlepathogenprogramssmall molecule
项目摘要
DESCRIPTION (provided by applicant): The AIDS epidemic caused by the HIV retrovirus is one of the leading threats posed to global health by an infectious agent. Limited availability of expensive anti-HIV drugs in the developing world, as well as emergence of drug-resistant HIV strains, highlight the continued need for identification and development of novel HIV prevention and treatment methods, drug targets and drugs. Disruption of viral assembly is a promising antiviral treatment strategy, but the progress in this direction has been slow due to the multivalent nature of the viral assembly process and due to the lack of efficient assembly assays suitable for drug screening and lead optimization. Our recent results revealed an evolutionary relationship between the zinc- finger associated SCAN domain and the retroviral capsid C-terminal domain (CA-CTD), and suggested a mechanism for capsid-mediated Gag oligomerization in retroviral assembly. The main hypothesis of this proposal is that the domain-swapped dimer observed in the SCAN structure represents a critical conformation of CA-CTD adopted during viral assembly. The functional clues provided by the SCAN structure will be used to identify critical molecular determinants of capsid dimerization, and to investigate the proposed role of the SCAN-like domain-swapped CA-CTD dimer (Aim 1). Sensitive and robust assays of CA-CTD dimerization will be developed and used for identification of capsid dimerization inhibitors by high throughput screening and rational design. The anti-HIV potential of the identified compounds will be evaluated (Aim 2).
描述(由申请人提供):由HIV逆转录病毒引起的艾滋病流行是传染病患者对全球健康构成的主要威胁之一。在发展中国家,昂贵的抗HIV药物的可用性有限,以及耐药艾滋病毒菌株的出现,突显了持续的鉴定和开发新型HIV预防和治疗方法,药物靶标和药物的需求。病毒组装的破坏是一种有希望的抗病毒治疗策略,但是由于病毒组装过程的多价性质,该方向的进展速度很慢,并且由于缺乏适合药物筛查和铅优化的有效组装测定法。我们最近的结果表明,锌指相关的扫描结构域与逆转录病毒C末端C末端结构域(CA-CTD)之间存在进化关系,并提出了一种在逆转录病毒组装中的衣壳介导的GAG寡聚的机制。该提议的主要假设是在扫描结构中观察到的域交换二聚体代表了病毒装配过程中采用的CA-CTD的临界构象。扫描结构提供的功能线索将用于识别衣壳二聚化的关键分子决定因素,并研究类似扫描域的CA-CTD二聚体所提出的作用(AIM 1)。通过高吞吐量筛选和合理设计,将开发并使用对CA-CTD二聚化的敏感和健壮的测定。将评估已确定化合物的抗HIV潜力(AIM 2)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DMITRI N IVANOV其他文献
DMITRI N IVANOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DMITRI N IVANOV', 18)}}的其他基金
Biochemistry of SAMHD1-mediated innate immunity responses
SAMHD1 介导的先天免疫反应的生物化学
- 批准号:
10212922 - 财政年份:2019
- 资助金额:
$ 22.74万 - 项目类别:
Biochemistry of SAMHD1-mediated innate immunity responses
SAMHD1 介导的先天免疫反应的生物化学
- 批准号:
10445349 - 财政年份:2019
- 资助金额:
$ 22.74万 - 项目类别:
Retroviral capsid recognition by TRIM5alpha restriction factors
TRIM5alpha 限制因子识别逆转录病毒衣壳
- 批准号:
9262531 - 财政年份:2014
- 资助金额:
$ 22.74万 - 项目类别:
Retroviral capsid recognition by TRIM5alpha restriction factors
TRIM5alpha 限制因子识别逆转录病毒衣壳
- 批准号:
8732420 - 财政年份:2014
- 资助金额:
$ 22.74万 - 项目类别:
Structural Basis of Retroviral Restriction by TRIM5alpha
TRIM5alpha 限制逆转录病毒的结构基础
- 批准号:
7898613 - 财政年份:2009
- 资助金额:
$ 22.74万 - 项目类别:
Structural Basis of Retroviral Restriction by TRIM5alpha
TRIM5alpha 限制逆转录病毒的结构基础
- 批准号:
7755507 - 财政年份:2009
- 资助金额:
$ 22.74万 - 项目类别:
Structural Basis of Retroviral Restriction by TRIM5alpha
TRIM5alpha 限制逆转录病毒的结构基础
- 批准号:
8055204 - 财政年份:2009
- 资助金额:
$ 22.74万 - 项目类别:
相似海外基金
Applying Deep Learning for Predicting Retention in PrEP Care and Effective PrEP Use among Key Populations at Risk for HIV in Thailand
应用深度学习预测泰国主要艾滋病毒高危人群中 PrEP 护理的保留情况以及 PrEP 的有效使用
- 批准号:
10619943 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别:
Strengthening the HIV prevention continuum using pharmacies
利用药房加强艾滋病毒预防连续性
- 批准号:
10619854 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别:
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
- 批准号:
10762645 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别:
Intersectional Stigma Reduction for Tajik Migrants Who Inject Drugs
减少注射毒品的塔吉克移民的跨部门耻辱
- 批准号:
10755435 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别:
Long-acting multi prevention implant for 2-year contraception and HIV PrEP
用于 2 年避孕和 HIV PrEP 的长效多重预防植入物
- 批准号:
10619811 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别: